Invention Grant
- Patent Title: Tenofovir alafenamide hemifumarate
-
Application No.: US13586358Application Date: 2012-08-15
-
Publication No.: US08697675B2Publication Date: 2014-04-15
- Inventor: Dazhan Liu , Bing Shi , Fang Wang , Richard Hung Chiu Yu
- Applicant: Dazhan Liu , Bing Shi , Fang Wang , Richard Hung Chiu Yu
- Applicant Address: US CA
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA
- Agency: Fitzpatrick, Cella, Harper & Scinto
- Main IPC: A61K31/685
- IPC: A61K31/685 ; C07F9/6561 ; C07D473/34
Abstract:
A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).
Public/Granted literature
- US08754065B2 Tenofovir alafenamide hemifumarate Public/Granted day:2014-06-17
Information query
